Diana S. M. Buist, PhD, MPH

Quality metrics for screening tests must evolve to mandate diagnostic resolution, ensuring financial and clinical incentives prioritize the complete screening continuum over initial test uptake.

Significant additional outreach and engagement strategies and incentives are likely required to increase adoption and ongoing use of health risk assessment tools among target populations.

Among older women in 5 integrated delivery systems, 14% experienced delayed radiotherapy for breast cancer, even though they had insurance and access to care.